skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
G250 Peptide Vaccine (Code C53410)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: G250 Peptide Vaccine

Definition: A cancer vaccine containing of a synthetic form of the renal cell carcinoma (RCC)-associated antigen G250 with potential antineoplastic activity. Vaccination with G250 peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for the G250 antigen, resulting in decreased tumor growth. Found in the majority of renal cell carcinomas, G250 is a cell surface tumor-associated antigen (TAA) that contains an HLA-A2.1-restricted epitope that is recognized by CTLs.

Label: G250 Peptide Vaccine

NCI Thesaurus Code: C53410 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1711251  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
G250 Peptide Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 465193
PDQ Open Trial Search ID 465193 (check for NCI PDQ open clinical trial info)
UMLS CUI C1711251

Other Properties:
     Name Value (qualifiers indented underneath)
code C53410
Legacy_Concept_Name G250_Peptide_Vaccine
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom